Podcast episode 17 (in German)
CJC-1295 + Ipamorelin: The popular growth hormone stack fact-checked
July 5, 2026
CJC-1295 and ipamorelin are among the most popular peptide combinations: together they are supposed to recreate the pulsing growth hormone pattern of younger years, through the body’s own production rather than from outside. The episode explains the logic of the stack and where the evidence is missing.
What it is about
Both peptides target the same goal via 2 different routes. CJC-1295 mimics GHRH, the body’s own signal for releasing growth hormone, and raises the baseline level. Ipamorelin acts via the ghrelin receptor and adds short, strong pulses on top. Because the body’s own feedback loop remains intact, the combination is considered a gentler, more physiological route than direct growth hormone. The episode clarifies the difference between CJC-1295 with and without DAC, tells the pharmaceutical origin of both substances and goes through the reported effects on sleep, recovery and skin. The conclusion is a stack that seems well thought out, made of 2 research peptides that never made it to approval.
Key points
- CJC-1295 is a GHRH analog and raises the baseline; ipamorelin is a selective ghrelin mimetic and triggers short growth hormone pulses.
- Older members of the ipamorelin class also drove up cortisol, prolactin and hunger; ipamorelin, by contrast, is considered particularly clean and does hardly any of this.
- DAC stands for Drug Affinity Complex: with this anchor, CJC-1295 binds to a blood protein and acts for days, without DAC only briefly; the short form is also called Mod GRF 1-29.
- CJC-1295 comes from the Canadian biotech company ConjuChem, ipamorelin from Novo Nordisk research; neither ever made it to market approval.
- Anecdotal report: users most often describe deeper sleep, plus better recovery, firmer skin and, over time, somewhat more lean mass; the skin effects take weeks.
- Growth hormone declines markedly with age, the so-called somatopause; the stack is meant to amplify this signal, in a pulsing and moderate way rather than permanently at maximum.
- Anecdotal report: as side effects, users mainly mention reactions at the injection site and a brief feeling of warmth or tingling after the injection.
Where the data stop
The episode relies on mechanism and user reports; it does not cite studies on the combination. How much the stack actually changes sleep, skin or muscle mass therefore remains open. Growth hormone and IGF-1 are double-edged for aging: that pulsing, moderate levels are more favorable than permanently high ones is a plausible consideration, not proof. With active cancer or unexplained growths, boosting IGF-1 would be delicate; with severe blood sugar problems caution is warranted, and blood sugar should be monitored in any case.
Neither peptide is approved as a medicine, as of July 2026, and both are banned in sport by WADA. What is offered comes from the gray market; quality and origin are decisive. Gentle does not mean harmless for everyone: anyone considering it should get professional advice.
Listen (in German)
Listen on Spotify Listen on Apple Podcasts Listen on Amazon Music
Published on July 5, 2026.
The topic in the database
- The popular GH stack: a GHRH analog plus a selective ghrelin peptide raise the body’s own growth hormone release in pulses – valued for deep sleep…CJC-1295 + Ipamorelin
All episodes in the app (German)
Information only, not medical advice and not a usage or dosage recommendation. Prescription-only and unapproved substances belong in the hands of a physician. Last updated: 2026-10-09.